Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person

Article Link: Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person

South San Francisco, CA — November 23, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for…

Source: FDA New Drug Approvals